Banca Mediolanum Valuation
Is ME1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ME1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ME1 (€10.76) is trading below our estimate of fair value (€11.86)
Significantly Below Fair Value: ME1 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ME1?
Key metric: As ME1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is ME1's PE Ratio? | |
|---|---|
| PE Ratio | 8.8x |
| Earnings | €924.04m |
| Market Cap | €8.16b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | -2.3x |
Price to Earnings Ratio vs Peers
How does ME1's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 19x | ||
HYQ Hypoport | 46.2x | 30.4% | €1.4b |
VVV3 Ökoworld | 8.8x | 5.5% | €198.6m |
DWS DWS Group GmbH KGaA | 13.1x | 12.7% | €7.8b |
DBK Deutsche Bank | 7.9x | 13.4% | €30.5b |
ME1 Banca Mediolanum | 8.8x | -3.9% | €8.2b |
Price-To-Earnings vs Peers: ME1 is good value based on its Price-To-Earnings Ratio (8.8x) compared to the peer average (19x).
Price to Earnings Ratio vs Industry
How does ME1's PE Ratio compare vs other companies in the European Diversified Financial Industry?
| 7 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: ME1 is good value based on its Price-To-Earnings Ratio (8.8x) compared to the European Diversified Financial industry average (10.7x).
Price to Earnings Ratio vs Fair Ratio
What is ME1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 8.8x |
| Fair PE Ratio | 14x |
Price-To-Earnings vs Fair Ratio: ME1 is good value based on its Price-To-Earnings Ratio (8.8x) compared to the estimated Fair Price-To-Earnings Ratio (14x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €10.76 | €12.85 +19.4% | 3.5% | €13.50 | €12.00 | n/a | 12 |
| Nov ’25 | €11.22 | €12.65 +12.7% | 4.4% | €13.50 | €11.70 | n/a | 12 |
| Oct ’25 | €11.15 | €12.53 +12.3% | 4.1% | €13.50 | €11.70 | n/a | 12 |
| Sep ’25 | €10.64 | €12.53 +17.7% | 4.1% | €13.50 | €11.70 | n/a | 12 |
| Aug ’25 | €10.56 | €12.23 +15.8% | 5.1% | €13.50 | €10.90 | n/a | 12 |
| Jul ’25 | €10.34 | €12.15 +17.5% | 4.6% | €13.00 | €10.90 | n/a | 12 |
| Jun ’25 | €10.24 | €12.12 +18.3% | 4.7% | €13.00 | €10.90 | n/a | 12 |
| May ’25 | €9.99 | €11.55 +15.6% | 5.5% | €12.80 | €10.80 | n/a | 12 |
| Apr ’25 | €10.05 | €11.38 +13.2% | 3.9% | €12.00 | €10.80 | n/a | 12 |
| Mar ’25 | €9.83 | €11.29 +14.8% | 3.6% | €12.00 | €10.80 | n/a | 12 |
| Feb ’25 | €9.30 | €10.88 +16.9% | 5.8% | €11.80 | €9.50 | n/a | 12 |
| Jan ’25 | €8.15 | €10.58 +29.8% | 6.3% | €11.50 | €9.20 | n/a | 12 |
| Dec ’24 | €8.02 | €10.60 +32.1% | 6.0% | €11.50 | €9.20 | n/a | 12 |
| Nov ’24 | €7.40 | €10.60 +43.2% | 6.0% | €11.50 | €9.20 | €11.22 | 12 |
| Oct ’24 | €8.00 | €10.69 +33.6% | 5.4% | €11.50 | €9.70 | €11.15 | 12 |
| Sep ’24 | €8.24 | €10.68 +29.6% | 5.4% | €11.50 | €9.70 | €10.64 | 12 |
| Aug ’24 | €8.54 | €10.71 +25.4% | 5.4% | €11.50 | €9.70 | €10.56 | 12 |
| Jul ’24 | €8.10 | €10.71 +32.3% | 4.4% | €11.40 | €9.80 | €10.34 | 12 |
| Jun ’24 | €7.82 | €10.78 +37.9% | 5.0% | €11.70 | €9.80 | €10.24 | 12 |
| May ’24 | €7.88 | €10.92 +38.5% | 4.3% | €11.70 | €10.00 | €9.99 | 12 |
| Apr ’24 | €8.17 | €10.96 +34.2% | 4.5% | €11.70 | €10.00 | €10.05 | 12 |
| Mar ’24 | €9.07 | €10.96 +20.8% | 4.5% | €11.70 | €10.00 | €9.83 | 12 |
| Feb ’24 | €8.68 | €9.80 +12.9% | 4.7% | €10.60 | €9.10 | €9.30 | 11 |
| Jan ’24 | €7.70 | €9.72 +26.2% | 4.4% | €10.50 | €9.10 | €8.15 | 11 |
| Dec ’23 | €7.73 | €9.58 +23.9% | 6.2% | €10.50 | €8.60 | €8.02 | 11 |
| Nov ’23 | €7.51 | €9.17 +22.0% | 4.2% | €9.70 | €8.60 | €7.40 | 10 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.40
7D
1.0%
1Y
22.2%
Mutares SE KGaA
€484.6m
A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.
MUX
€22.40
7D
1.1%
1Y
-29.3%
Merchants Bancorp
US$1.9b
Operates as the diversified bank holding company in the United States.
3KD
US$39.20
7D
5.9%
1Y
31.5%